NL7217831A - - Google Patents

Info

Publication number
NL7217831A
NL7217831A NL7217831A NL7217831A NL7217831A NL 7217831 A NL7217831 A NL 7217831A NL 7217831 A NL7217831 A NL 7217831A NL 7217831 A NL7217831 A NL 7217831A NL 7217831 A NL7217831 A NL 7217831A
Authority
NL
Netherlands
Application number
NL7217831A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7217831A publication Critical patent/NL7217831A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
NL7217831A 1972-01-22 1972-12-29 NL7217831A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722203048 DE2203048A1 (de) 1972-01-22 1972-01-22 Wasserloesliche sterinsulfate

Publications (1)

Publication Number Publication Date
NL7217831A true NL7217831A (en:Method) 1973-07-24

Family

ID=5833749

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7217831A NL7217831A (en:Method) 1972-01-22 1972-12-29

Country Status (17)

Country Link
US (1) US3836527A (en:Method)
JP (1) JPS4881847A (en:Method)
AT (1) AT323344B (en:Method)
AU (1) AU465860B2 (en:Method)
BE (1) BE794362A (en:Method)
BR (1) BR7300391D0 (en:Method)
CH (1) CH578019A5 (en:Method)
DD (1) DD102693A5 (en:Method)
DE (1) DE2203048A1 (en:Method)
DK (1) DK129991B (en:Method)
ES (1) ES410828A1 (en:Method)
FR (1) FR2181680B1 (en:Method)
GB (1) GB1367025A (en:Method)
HU (1) HU164290B (en:Method)
IL (1) IL41234A (en:Method)
NL (1) NL7217831A (en:Method)
ZA (1) ZA729168B (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021458A (en) * 1974-04-18 1977-05-03 Schering Aktiengesellschaft Process for the preparation of 3-hemisulfate-17α-hydroxy steroids
US4264512A (en) * 1975-09-29 1981-04-28 The Regents Of The University Of California 3-Deoxy-1α-hydroxy- and 3-deoxy-1α,25-dihydroxycholecalciferol and processes for the preparation thereof
DE19642875B4 (de) * 1996-10-17 2004-08-26 Cognis Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Sterolsulfaten
IL138664A0 (en) * 1998-03-26 2001-10-31 Phytopharm Plc Smilagenin and anzurogenin-d for the treatment of alheimer's disease
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
WO2004058795A1 (en) * 2002-12-24 2004-07-15 The University Of British Columbia Angiogenic compounds and uses thereof
ITMI20030822A1 (it) * 2003-04-18 2004-10-19 Erregierre Spa Processo per la preparazione dell'acido ursodesossicolico
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
HRP20220978T1 (hr) 2013-12-24 2022-11-11 Virginia Commonwealth University Upotreba oksidiranih kolesterol sulfata (ocs) za liječenje disfunkcije bubrega
SMT202200330T1 (it) 2016-08-02 2022-11-18 Univ Virginia Commonwealth Composizioni comprendenti 5-colesten-3, 25-diolo, 3-solfato (25hc3s) o suo sale farmaceuticamente accettabile e almeno un oligosaccaride ciclico

Also Published As

Publication number Publication date
FR2181680B1 (en:Method) 1975-10-10
DK129991B (da) 1974-12-09
AU465860B2 (en) 1975-10-09
AU5127873A (en) 1974-07-25
BE794362A (fr) 1973-07-23
FR2181680A1 (en:Method) 1973-12-07
ES410828A1 (es) 1976-04-16
DK129991C (en:Method) 1975-05-20
AT323344B (de) 1975-07-10
GB1367025A (en) 1974-09-18
DE2203048A1 (de) 1973-08-16
IL41234A (en) 1976-05-31
CH578019A5 (en:Method) 1976-07-30
BR7300391D0 (pt) 1973-10-25
US3836527A (en) 1974-09-17
HU164290B (en:Method) 1974-01-28
IL41234A0 (en) 1973-03-30
JPS4881847A (en:Method) 1973-11-01
ZA729168B (en) 1973-09-26
DD102693A5 (en:Method) 1973-12-20

Similar Documents

Publication Publication Date Title
BR7310191D0 (en:Method)
DD102693A5 (en:Method)
CH1233573A4 (en:Method)
BG18114A1 (en:Method)
BG18165A1 (en:Method)
BG18732A1 (en:Method)
BG26793A1 (en:Method)
CH1029173A4 (en:Method)
CH1102374A4 (en:Method)
CH1117573A4 (en:Method)
AU479695A (en:Method)
CH150673A4 (en:Method)
CH159072A4 (en:Method)
CH228872A4 (en:Method)
CH326073A4 (en:Method)
CH546010A (en:Method)
CH559787A5 (en:Method)
CH561882A5 (en:Method)
CH561916A5 (en:Method)
CH562529A5 (en:Method)
CH562618A5 (en:Method)
CH562671A5 (en:Method)
CH566493A5 (en:Method)
CH567354A5 (en:Method)
CH567389A5 (en:Method)